↑ Rising
Business
Why Arrowhead Shot Sky-High, While Ionis Toppled
Arrowhead Pharmaceuticals shares surged following positive Phase 3 trial results for its lipid-lowering drug, impacting competitor Ionis.
Plozasiran
1 trends tracked about this subject — the full history, oldest to newest below.